The expected outcomes of the preparation stage will be:
- Completed tender documents based on the Horizon 2020 PCP model contract documents, using common functional/performance based specifications and common evaluation criteria.
- Signed joint procurement agreement confirming the final collaboration modus including the financial commitment of the buyers group to pool resources for the PCP; and
- Final confirmation of the lead procurer.
Finally, the results will be disseminated and the ex-post exploitation strategy based on the outcomes of the PCP will be confirmed.
The PCP execution consist of 3 phases:
This phase is a feasibility study of the selected technologies and proposals, which aims to verify the technical, economic and
organizational feasibility of each company’s offer. The expected output from participating companies is a report describing the
results of the feasibility study and the conclusions for the start of the development activities in Phase B.
The expectation is that this phase will last for 6 months. The budget for the R&D contracts in this phase is 378,000 Euros.
This represents 20% of the total budget for the PCP call. From this sum a maximum of eight contracts will be awarded.
The purpose of this phase is to take the most promising ideas that have been shown to be feasible in Phase A and develop them
into well-defined prototypes. The selection process for Phase B is based on the Phase A report and an application process, which
will outline the company’s plans for Phase B.
Selected companies will each develop a prototype based on the results of their feasibility study. The aim is to verify to what
extent the prototype’s main features meet the functional and performance requirements set in the challenge. Participating
companies are expected to deliver a prototype specification and lab demonstration, as well as a plan for original development
of a limited volume of first solutions and field-testing, and an updated cost/benefits evaluation including a preliminary business
plan.
It is expected that the combined budget for this phase will be 661.500 Euros. This is 40% of the total budget for the PCP R&D contracts.
A maximum of four projects will be selected for Phase B and this phase is expected to take up to six months.
This phase aims to verify and compare the full feature set and performance of different solutions in real-life operational conditions.
Selected companies will each develop a prototype based on the results of their feasibility study. The selection process is based on
the Feasibility Study Report which will outline the company’s plans for the field test.
The aim is to verify to what extent the prototype’s main features meet the functional and performance requirements set in the challenge.
Participating companies are expected to deliver a prototype specification, as well as a plan for original development of a limited
volume of first solutions and field-testing, and an updated cost/benefits evaluation including a preliminary business plan.
Testing is undertaken at three sites by the procurers. This phase will last maximum 6 months All solutions in Phase C are tested in
all sites to ensure that a comparison can be made of performance both across sites and across solutions.SAS; RESAH and CCU will identify
collaborating patients and hospitals and will lead the proof of concept. FHF and UOC will collaborate in assessing the impact and
adherence of the patients to the solutions awarded.
It is expected that the combined budget for this phase will be 850,500 Euros. This is 40% of the total budget for the PCP Research
and Development contracts. Phase C is expected to take a year and a half with no more than two solutions progressing to this phase
depending on their results from Phase B. At the conclusion of the Research and Development pilots the IPR and any prototypes will remain
the property of the companies involved.
The three “phases” of Solution design, Prototype development and Pre-Commercial small-scale development and field test fall within
the scope of the RELIEF PCP call.
